E-LIB Suche - Ergebnisse für: Rivero-Hinojosa, Samuel

1

Post-surgical ctDNA-based molecular residual disease detect..:

Recio, Fernando ; Scalise, Carly Bess ; Loar, Paul...
Gynecologic Oncology. 182 (2024) - p. 63-69 , 2024

Link: https://doi.org/10.1016/..

2

BORIS/CTCFL epigenetically reprograms clustered CTCF bindin..:

Pugacheva, Elena M. ; Bhatt, Dharmendra Nath ; Rivero-Hinojosa, Samuel...
Genome Biology. 25 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Association of personalized and tumor-informed ctDNA with p..:

Botta, Gregory P ; Abdelrahim, Maen ; Drengler, Ronald L...
The Oncologist. , 2024

Link: https://doi.org/10.1093/..

4

MDB-45. THE PTBP2 SPLICING FACTOR IS ESSENTIAL IN GROUP 3/4..:

Caisova, Veronika ; Rivero-Hinojosa, Samuel ; Tardito, Samuele...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

5

MDB-110. A NOVEL TRANSGENIC MOUSE MODEL FOR GLI2-AMPLIFIED ..:

Murad, Najiba ; Xu, Zhenhua ; Liu, Xiao...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

6

Association of Tumor-informed Circulating Tumor DNA Detecta..:

Sfakianos, John P. ; Basu, Arnab ; Laliotis, George...
European Urology Oncology. , 2024

Link: https://doi.org/10.1016/..

7

A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the T..:

Loukinov, Dmitri ; Anderson, Amanda Laust ; Mkrtichyan, Mikayel...
International Journal of Molecular Sciences. 24 (2023) 6 - p. 5976 , 2023

Link: https://doi.org/10.3390/..

8

MDB-17. THE PTBP2 SPLICING FACTOR IS ESSENTIAL IN GROUP 3/4..:

Caisova, Veronika ; Rivero-Hinojosa, Samuel ; Chintala, Navya...
Neuro-Oncology. 25 (2023) Supplement_1 - p. i65-i65 , 2023

Link: https://doi.org/10.1093/..

9

EMBR-02. OLIG2 REPRESENTS A PROGNOSTIC MARKER AND THERAPEUT..:

Xu, Zhenhua ; Murad, Najiba ; Rivero-Hinojosa, Samuel...
Neuro-Oncology. 23 (2021) Supplement_1 - p. i5-i6 , 2021

Link: https://doi.org/10.1093/..

10

The combined action of CTCF and its testis-specific paralog..:

Rivero-Hinojosa, Samuel ; Pugacheva, Elena M. ; Kang, Sungyun...
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

11

RE: Clinical Characteristics and Outcomes of COVID-19–Infec..:

Huang, Yuting ; Rivero-Hinojosa, Samuel ; Ma, Yuchi..
JNCI: Journal of the National Cancer Institute. 113 (2021) 8 - p. 1109-1110 , 2021

Link: https://doi.org/10.1093/..

12

Proteogenomic discovery of neoantigens facilitates personal..:

Rivero-Hinojosa, Samuel ; Grant, Melanie ; Panigrahi, Aswini...
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

13

IMMU-15. PROTEOGENOMIC DISCOVERY OF NOVEL TUMOR PEPTIDES AS..:

Rivero-Hinojosa, Samuel ; Grant, Melanie ; Panigrahi, Aswini...
Neuro-Oncology. 22 (2020) Supplement_3 - p. iii362-iii363 , 2020

Link: https://doi.org/10.1093/..

14

Germline microsatellite genotypes differentiate children wi..:

Rivero-Hinojosa, Samuel ; Kinney, Nicholas ; Garner, Harold R.
Neuro-Oncology. 22 (2019) 1 - p. 152-162 , 2019

Link: https://doi.org/10.1093/..

15

PDTM-13. OVEREXPRESSION OF MYC ALONE IS SUFFICIENT TO INITI..:

Tao, Ran ; Murad, Najiba ; Xu, Zhenhua...
Neuro-Oncology. 20 (2018) suppl_6 - p. vi206-vi206 , 2018

Link: https://doi.org/10.1093/..